Form 4 for HCAT Health Catalyst, Inc.
Accepted 2021-12-15 00:00:00 ET · period of report 2021-12-13 · accession 0001562180-21-007708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-15 | 2021-12-13 | HCAT | Nelli James Patrick Jr. | Pres | M - OptEx | $9.77 | +25.0K | 119.0K | +27% | +$244.2K |
| DM | 2021-12-15 | 2021-12-13 | HCAT | Nelli James Patrick Jr. | Pres | M - OptEx | $0.00 | -25.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-13 | M | A | 6,500 | $10.60 | 125,462 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-13 | M | A | 15,464 | $9.24 | 140,926 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-13 | M | A | 3,036 | $10.66 | 118,962 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-12-13 | M | D | 15,464 | $0.00 | 0 | D | $9.24 · — to 2025-02-10 | 15,464 Common Stock | (F3) 25% of the 18,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on February 10, 2019. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-12-13 | M | D | 3,036 | $0.00 | 12,051 | D | $10.66 · — to 2027-04-27 | 3,036 Common Stock | (F1) 25% of the 15,087 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 27, 2021. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-12-13 | M | D | 6,500 | $0.00 | 0 | D | $10.60 · — to 2026-10-14 | 6,500 Common Stock | (F2) 25% of the 6,500 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on October 14, 2020. |